Ii Robert C. Goeltz Arcus Biosciences, Inc. (RCUS) insider trading activity
Ii Robert C. Goeltz is Chief Financial Officer of Arcus Biosciences, Inc.. Currently has a direct ownership of 63,732 shares of RCUS, which is worth approximately $987,846. The most recent transaction as insider was on Dec 15, 2024, when has been sold 10,099 shares (Common Stock) at a price of $16.08 per share, resulting in proceeds of $162,391. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
63.7K
12.85%
3M change
18.38%
12M change
Total Value Held
$987,846
II Robert C. Goeltz Transaction History
IRC
Ii Robert C. Goeltz
Chief Financial Officer
Hayward, CA